Neurovascular Intervention Articles & Analysis
11 news found
” Confluent supports some of the fastest growing medical device markets such as Interventional Neurovascular, Electrophysiology, Structural Heart, and Peripheral Vascular. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. ...
Additionally, we can complete the intervention whilst being totally protected by sitting in front of the X-ray-proof console and manipulating the devices using only the joysticks. ...
ByRobocath
Rapid Medical, a leading developer of advanced neurovascular devices, announces the expansion of its portfolio in the United States and the first Numen™ coil embolization procedure. ...
Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. ...
Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems and finished devices for medical device OEMs in many of the fastest growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular and ENT. ...
The procedure took place at the 301 Hospital in Beijing on November 24; performed by Dr. Yundai Chen, a renowned interventional cardiologist and author of several scientific publications. ...
ByRobocath
Lori Adels, Chief Compliance Officer of Cerus Endovascular, added, "Seven of the leading interventional neurovascular sites in the U.S. have already agreed to be active contributors to this study, a testament to the importance of this innovative device." About the Contour Neurovascular System The Contour Neurovascular ...
We recognize that not all neurovascular interventions can be displaced by robotic surgery due to the complexity of vascular and aneurysm anatomies, however this accomplishment does demonstrate promise for procedures to be performed like this in the future. ...
“The field of neurovascular intervention is changing rapidly, but there remains a significant need to expand access to care and reduce treatment times,” said Mark Toland, CEO of Corindus. “Implementing robotic capability for neurovascular intervention is the first step toward our vision of providing ...
“The team at Q’Apel is developing the most innovative products used in neurovascular interventions. We are excited about the future of Q’Apel and believe King brings the experience and leadership needed to take Q’Apel to the next level of success,” said Chris Martin, Director, Q’Apel ...